Latest news
Exclusive: Pathos AI signs two deals, plans to raise Series E at $3B valuation - Endpoints NewsEndpoints News · Tue, 04 Aug 2026 00:00:00 GMTJohnson & Johnson Trimmed Its 2026 Profit Outlook After Two Biotech Deals - FinimizeFinimize · Wed, 29 Jul 2026 17:24:34 GMTCaldera, Vidya add to recent flurry of biotech mergers - BioPharma DiveBioPharma Dive · Wed, 29 Jul 2026 07:00:00 GMTWhy Chinese Biotech Licensing Deals Became Attractive to US Investors - Pharmaceutical ExecutivePharmaceutical Executive · Wed, 29 Jul 2026 07:00:00 GMTChinese biotech is stealing the emerging market trade that AI dominated for two years - Startup FortuneStartup Fortune · Mon, 27 Jul 2026 00:14:27 GMT